Key result
New-onset heart failure was associated with higher 6-month survival without death or rehospitalization compared to acutely decompensated chronic heart failure in elderly patients (P=0.001).
Why the study?
Coexisting morbidities are common in patients with heart failure, but their burden and clinical significance needed evaluation in elderly hospitalized patients with new-onset versus acutely decompensated chronic heart failure.
Does the coexisting morbidity burden and clinical outcome differ between hospitalized elderly patients with new-onset heart failure versus acutely decompensated chronic heart failure?
Observational (n=206)
Does the coexisting morbidity burden and clinical outcome differ between hospitalized elderly patients with new-onset heart failure versus acutely decompensated chronic heart failure?
p-value: p=0.001
Elderly patients with acutely decompensated chronic heart failure have a higher coexisting morbidity burden and worse 6-month clinical outcomes compared to those with new-onset heart failure.
Supports differential prognosis by HF onset in elderly inpatients; leaves open whether multimorbidity-targeted strategies improve ADCHF outcomes.
Coexisting morbidities (CM) are common in patients with heart failure (HF). This study evaluated the CM burden and its clinical significance in elderly hospitalized patients with new-onset (De-novo) HF (n = 84) and acutely decompensated chronic HF (ADCHF) (n = 122). All had HF symptoms associated with: (a) LVEF <50%, or, (b) left ventricular ejection fraction (LVEF) ≥50% and NT-proBNP ≥300 pg/mL. The primary endpoint was the composite of all-cause death/HF rehospitalization at 6 months. Age was similar between patients with new-onset HF and ADCHF [82 (12.5) vs 80 (11) years, respectively; P = .549]. The CM burden was high in both groups. However, the number of CM [3 (2) vs 4 (1.75)] and the prevalence of multimorbidity [CM ≥2; 65 (77.4%) vs 108 (88.5%)] were lower in new-onset HF ( P = .016 and P = .035, respectively). The survival probability without the primary endpoint was higher in new-onset HF than in ADCHF ( P = .001) driven by less rehospitalizations ( P = .001). In the total study population significant primary endpoint predictors were red blood cell distribution width (RDW), urea, and coronary artery disease (CAD) prevalence (AUC of the model =.7685), whereas significant death predictors were RDW, urea, and the number of CM (AUC = .7859), all higher in ADCHF. Thus, the higher CM burden in ADCHF than in new-onset HF most likely contributed to the worse outcome.
No takes yet. Share an insight, caveat, or question.
Xanthopoulos et al. (2022) conducted an observational in Heart failure (n=206). New-onset heart failure vs. Acutely decompensated chronic heart failure was evaluated on Composite of all-cause death/HF rehospitalization at 6 months (p=0.001). New-onset heart failure was associated with higher 6-month survival without death or rehospitalization compared to acutely decompensated chronic heart failure in elderly patients (P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: